Clinical Trials List
Protocol NumberMK3475-199
2016-07-01 - 2020-03-31
Phase II
Terminated2
ICD-9185
Malignant neoplasm of prostate
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chia-Chi Lin Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- CHUNG-HSIN CHEN Division of Urology
- Yu-Chieh Tsai Division of Hematology & Oncology
- - - Division of Urology
- Yeong-Shiau Pu Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
- Hsiao-Jen Chung Division of Urology
- 朱力行 Division of Nuclear Medicine
- 沈書慧 Division of Radiology
- Tzu-Ping Lin Division of Urology
- Tzu-chun Wei Division of Urology
- Yi-Hsiu Huang Division of Urology
- 潘競成 Division of Others
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
370 participants
